<DOC>
	<DOC>NCT01333735</DOC>
	<brief_summary>The aim of the study is to investigate the impact of adjuvant chemotherapy on cognitive function in patients aged over 65 and suffering from breast cancer or colon.</brief_summary>
	<brief_title>Impact on Cognitive Function and Quality of Life of Adjuvant Chemotherapy in Patients Aged Over 65 Years: Application to Breast Cancer or Colon</brief_title>
	<detailed_description />
	<mesh_term>Breast Neoplasms</mesh_term>
	<criteria>Inclusion Criteria for patients with chemotherapy : Patient(e) aged over 65 years Non metastatic breast cancer Adjuvant chemotherapy Breast cancer: FEC, including Docetaxel Protocols No major cognitive impairment Lack of personality disorders and psychiatric disorders evolutionary Having signed the informed consent of study participation Inclusion Criteria for patients without chemotherapy (control group): Patient(e) aged over 65 years Breast cancer Patients receiving no adjuvant chemotherapy No major cognitive impairment Lack of personality disorders and psychiatric disorders evolutionary Having signed the informed consent of study participation Matching on age, sex, cultural level and tumor location Exclusion Criteria for patients with chemotherapy : Metastatic Cancer primitive other than breast Patients under 65 years Patients with adjuvant chemotherapy is associated with targeted therapy Patients who have received other cancer treatments (chemotherapy or radiotherapy brain) disorders of higher functions existing in the administration of chemotherapy Pathology psychiatric evolutionary Refusal of participation Patients unable to meet the cognitive tests Drug use Heavy drinking</criteria>
	<gender>Female</gender>
	<minimum_age>66 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2015</verification_date>
	<keyword>cognitive functions</keyword>
	<keyword>quality of life</keyword>
	<keyword>breast cancer</keyword>
	<keyword>chemotherapy</keyword>
	<keyword>ages patients</keyword>
</DOC>